NM_001429.4:c.6798_6800delGCA

Variant summary

Our verdict is Benign. Variant got -11 ACMG points: 1P and 12B. PM4_SupportingBP6_Very_StrongBS2

The NM_001429.4(EP300):​c.6798_6800delGCA​(p.Gln2267del) variant causes a disruptive inframe deletion change. The variant allele was found at a frequency of 0.00378 in 1,613,788 control chromosomes in the GnomAD database, including 15 homozygotes. Variant has been reported in ClinVar as Likely benign (★★).

Frequency

Genomes: 𝑓 0.0023 ( 0 hom., cov: 32)
Exomes 𝑓: 0.0039 ( 15 hom. )

Consequence

EP300
NM_001429.4 disruptive_inframe_deletion

Scores

Not classified

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts P:1B:11O:1

Conservation

PhyloP100: 6.12
Variant links:
Genes affected
EP300 (HGNC:3373): (E1A binding protein p300) This gene encodes the adenovirus E1A-associated cellular p300 transcriptional co-activator protein. It functions as histone acetyltransferase that regulates transcription via chromatin remodeling and is important in the processes of cell proliferation and differentiation. It mediates cAMP-gene regulation by binding specifically to phosphorylated CREB protein. This gene has also been identified as a co-activator of HIF1A (hypoxia-inducible factor 1 alpha), and thus plays a role in the stimulation of hypoxia-induced genes such as VEGF. Defects in this gene are a cause of Rubinstein-Taybi syndrome and may also play a role in epithelial cancer. [provided by RefSeq, Jul 2008]
EP300-AS1 (HGNC:50504): (EP300 antisense RNA 1)

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Benign. Variant got -11 ACMG points.

PM4
Nonframeshift variant in NON repetitive region in NM_001429.4. Strenght limited to Supporting due to length of the change: 1aa.
BP6
Variant 22-41178506-TCAG-T is Benign according to our data. Variant chr22-41178506-TCAG-T is described in ClinVar as [Likely_benign]. Clinvar id is 341826.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr22-41178506-TCAG-T is described in Lovd as [Likely_benign].
BS2
High AC in GnomAd4 at 343 AD gene.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
EP300NM_001429.4 linkc.6798_6800delGCA p.Gln2267del disruptive_inframe_deletion Exon 31 of 31 ENST00000263253.9 NP_001420.2 Q09472Q7Z6C1
EP300NM_001362843.2 linkc.6720_6722delGCA p.Gln2241del disruptive_inframe_deletion Exon 30 of 30 NP_001349772.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
EP300ENST00000263253.9 linkc.6798_6800delGCA p.Gln2267del disruptive_inframe_deletion Exon 31 of 31 1 NM_001429.4 ENSP00000263253.7 Q09472
EP300ENST00000674155.1 linkc.6720_6722delGCA p.Gln2241del disruptive_inframe_deletion Exon 30 of 30 ENSP00000501078.1 A0A669KB12
ENSG00000232754ENST00000415054.1 linkn.82+4554_82+4556delCTG intron_variant Intron 1 of 2 3
EP300-AS1ENST00000420537.1 linkn.224-3685_224-3683delCTG intron_variant Intron 2 of 2 3

Frequencies

GnomAD3 genomes
AF:
0.00226
AC:
343
AN:
151800
Hom.:
0
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.000920
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00216
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.000208
Gnomad FIN
AF:
0.0000945
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00392
Gnomad OTH
AF:
0.00192
GnomAD3 exomes
AF:
0.00186
AC:
467
AN:
251286
Hom.:
1
AF XY:
0.00179
AC XY:
243
AN XY:
135814
show subpopulations
Gnomad AFR exome
AF:
0.000923
Gnomad AMR exome
AF:
0.00139
Gnomad ASJ exome
AF:
0.0000994
Gnomad EAS exome
AF:
0.00
Gnomad SAS exome
AF:
0.000457
Gnomad FIN exome
AF:
0.000139
Gnomad NFE exome
AF:
0.00331
Gnomad OTH exome
AF:
0.00163
GnomAD4 exome
AF:
0.00394
AC:
5753
AN:
1461868
Hom.:
15
AF XY:
0.00378
AC XY:
2752
AN XY:
727232
show subpopulations
Gnomad4 AFR exome
AF:
0.000538
Gnomad4 AMR exome
AF:
0.00159
Gnomad4 ASJ exome
AF:
0.0000765
Gnomad4 EAS exome
AF:
0.0000252
Gnomad4 SAS exome
AF:
0.000591
Gnomad4 FIN exome
AF:
0.000169
Gnomad4 NFE exome
AF:
0.00484
Gnomad4 OTH exome
AF:
0.00361
GnomAD4 genome
AF:
0.00226
AC:
343
AN:
151920
Hom.:
0
Cov.:
32
AF XY:
0.00199
AC XY:
148
AN XY:
74268
show subpopulations
Gnomad4 AFR
AF:
0.000917
Gnomad4 AMR
AF:
0.00216
Gnomad4 ASJ
AF:
0.00
Gnomad4 EAS
AF:
0.00
Gnomad4 SAS
AF:
0.000208
Gnomad4 FIN
AF:
0.0000945
Gnomad4 NFE
AF:
0.00392
Gnomad4 OTH
AF:
0.00190
Alfa
AF:
0.00268
Hom.:
0
Bravo
AF:
0.00227
EpiCase
AF:
0.00398
EpiControl
AF:
0.00362

ClinVar

Significance: Benign/Likely benign
Submissions summary: Pathogenic:1Benign:11Other:1
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:5
Aug 24, 2017
Center for Pediatric Genomic Medicine, Children's Mercy Hospital and Clinics
Significance: Likely benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

-
Laboratory of Diagnostic Genome Analysis, Leiden University Medical Center (LUMC)
Significance: Likely benign
Review Status: no assertion criteria provided
Collection Method: clinical testing

- -

Mar 01, 2025
CeGaT Center for Human Genetics Tuebingen
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

EP300: PM4:Supporting, BS1, BS2 -

-
Diagnostic Laboratory, Department of Genetics, University Medical Center Groningen
Significance: Likely benign
Review Status: no assertion criteria provided
Collection Method: clinical testing

- -

Nov 06, 2018
GeneDx
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

This variant is associated with the following publications: (PMID: 24728327, 27416986, 26960974) -

Rubinstein-Taybi syndrome due to EP300 haploinsufficiency Pathogenic:1Benign:2
Jan 13, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

Nov 05, 2019
Wessex Regional Genetics Laboratory, Salisbury District Hospital
Significance: Pathogenic
Review Status: no assertion criteria provided
Collection Method: clinical testing

- -

May 04, 2023
Molecular Genetics, Royal Melbourne Hospital
Significance: Likely benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

European Non-Finnish population allele frequency is 0.3034% (rs533875300, 430/128992 alleles, 0 homozygotes in gnomAD v2.1). Based on the classification scheme RMH Modified ACMG/AMP Guidelines v1.4.0, this variant is classified as LIKELY BENIGN. Following criteria are met: BS1 -

Rubinstein-Taybi syndrome due to CREBBP mutations Benign:2
May 28, 2019
Mendelics
Significance: Likely benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

Jun 14, 2016
Illumina Laboratory Services, Illumina
Significance: Likely benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

not specified Benign:1Other:1
Sep 19, 2013
ITMI
Significance: not provided
Review Status: no classification provided
Collection Method: reference population

- -

Nov 08, 2016
Eurofins Ntd Llc (ga)
Significance: Likely benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

EP300-related disorder Benign:1
May 15, 2019
PreventionGenetics, part of Exact Sciences
Significance: Likely benign
Review Status: no assertion criteria provided
Collection Method: clinical testing

This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs533875300; hg19: chr22-41574510; API